Literature DB >> 33579999

Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens.

Zachary D Wallen1, Mary Appah1, Marissa N Dean1, Cheryl L Sesler1, Stewart A Factor2, Eric Molho3, Cyrus P Zabetian4, David G Standaert1, Haydeh Payami5.   

Abstract

In Parkinson's disease (PD), gastrointestinal features are common and often precede the motor signs. Braak and colleagues proposed that PD may start in the gut, triggered by a pathogen, and spread to the brain. Numerous studies have examined the gut microbiome in PD; all found it to be altered, but found inconsistent results on associated microorganisms. Studies to date have been small (N = 20 to 306) and are difficult to compare or combine due to varied methodology. We conducted a microbiome-wide association study (MWAS) with two large datasets for internal replication (N = 333 and 507). We used uniform methodology when possible, interrogated confounders, and applied two statistical tests for concordance, followed by correlation network analysis to infer interactions. Fifteen genera were associated with PD at a microbiome-wide significance level, in both datasets, with both methods, with or without covariate adjustment. The associations were not independent, rather they represented three clusters of co-occurring microorganisms. Cluster 1 was composed of opportunistic pathogens and all were elevated in PD. Cluster 2 was short-chain fatty acid (SCFA)-producing bacteria and all were reduced in PD. Cluster 3 was carbohydrate-metabolizing probiotics and were elevated in PD. Depletion of anti-inflammatory SCFA-producing bacteria and elevated levels of probiotics are confirmatory. Overabundance of opportunistic pathogens is an original finding and their identity provides a lead to experimentally test their role in PD.

Year:  2020        PMID: 33579999     DOI: 10.1038/s41531-020-0112-6

Source DB:  PubMed          Journal:  NPJ Parkinsons Dis        ISSN: 2373-8057


  69 in total

Review 1.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

Review 2.  Advances in environmental epidemiology.

Authors:  Caroline M Tanner
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

3.  Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease.

Authors:  Joanna M Biernacka; Sun Ju Chung; Sebastian M Armasu; Kari S Anderson; Christina M Lill; Lars Bertram; J E Ahlskog; Laura Brighina; Roberta Frigerio; Demetrius M Maraganore
Journal:  Parkinsonism Relat Disord       Date:  2016-08-03       Impact factor: 4.891

4.  Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease.

Authors:  Madelyn C Houser; Jianjun Chang; Stewart A Factor; Eric S Molho; Cyrus P Zabetian; Erin M Hill-Burns; Haydeh Payami; Vicki S Hertzberg; Malú G Tansey
Journal:  Mov Disord       Date:  2018-03-23       Impact factor: 10.338

Review 5.  The Human Gut Microbiome: From Association to Modulation.

Authors:  Thomas S B Schmidt; Jeroen Raes; Peer Bork
Journal:  Cell       Date:  2018-03-08       Impact factor: 41.582

6.  Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee.

Authors:  Taye H Hamza; Honglei Chen; Erin M Hill-Burns; Shannon L Rhodes; Jennifer Montimurro; Denise M Kay; Albert Tenesa; Victoria I Kusel; Patricia Sheehan; Muthukrishnan Eaaswarkhanth; Dora Yearout; Ali Samii; John W Roberts; Pinky Agarwal; Yvette Bordelon; Yikyung Park; Liyong Wang; Jianjun Gao; Jeffery M Vance; Kenneth S Kendler; Silviu-Alin Bacanu; William K Scott; Beate Ritz; John Nutt; Stewart A Factor; Cyrus P Zabetian; Haydeh Payami
Journal:  PLoS Genet       Date:  2011-08-18       Impact factor: 5.917

7.  Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease.

Authors:  Christopher B Forsyth; Kathleen M Shannon; Jeffrey H Kordower; Robin M Voigt; Maliha Shaikh; Jean A Jaglin; Jacob D Estes; Hemraj B Dodiya; Ali Keshavarzian
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

8.  Meta-analyses on prevalence of selected Parkinson's nonmotor symptoms before and after diagnosis.

Authors:  Honglei Chen; Edward J Zhao; Wen Zhang; Yi Lu; Rui Liu; Xuemei Huang; Anna J Ciesielski-Jones; Michele A Justice; Deborah S Cousins; Shyamal Peddada
Journal:  Transl Neurodegener       Date:  2015-01-08       Impact factor: 8.014

9.  A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci.

Authors:  Diana Chang; Mike A Nalls; Ingileif B Hallgrímsdóttir; Julie Hunkapiller; Marcel van der Brug; Fang Cai; Geoffrey A Kerchner; Gai Ayalon; Baris Bingol; Morgan Sheng; David Hinds; Timothy W Behrens; Andrew B Singleton; Tushar R Bhangale; Robert R Graham
Journal:  Nat Genet       Date:  2017-09-11       Impact factor: 38.330

10.  A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease.

Authors:  E M Hill-Burns; N Singh; P Ganguly; T H Hamza; J Montimurro; D M Kay; D Yearout; P Sheehan; K Frodey; J A McLear; M B Feany; S D Hanes; W J Wolfgang; C P Zabetian; S A Factor; H Payami
Journal:  Pharmacogenomics J       Date:  2012-10-02       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.